Search Results - "Jasmina Ziva Cerne"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study by Cerne, Jasmina-Ziva, Stegel, Vida, Gersak, Ksenija, Novakovic, Srdjan

    Published in BMC cancer (22-03-2012)
    “…A single nucleotide polymorphism located in the 3'-untranslated region of the KRAS oncogene (KRAS variant; rs61764370) disrupts a let-7 miRNA binding and was…”
    Get full text
    Journal Article
  2. 2

    Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer by Cerne, Jasmina-Ziva, Pohar-Perme, Maja, Novakovic, Srdjan, Frkovic-Grazio, Snjezana, Stegel, Vida, Gersak, Ksenija

    Published in Journal of gynecologic oncology (30-06-2011)
    “…Estrogen plays a key role in breast cancer development and functionally relevant genetic variants within the estrogen metabolic pathway are prime candidates…”
    Get full text
    Journal Article
  3. 3

    Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer by Jasmina Ziva Cerne, Maja Pohar Perme, Srdjan Novakovic, Snjezana Frkovic Grazio, Vida Stegel, Ksenija Gersak

    Published in Journal of gynecologic oncology (20-06-2011)
    “…Objective: Estrogen plays a key role in breast cancer development and functionally relevant genetic variants within the estrogen metabolic pathway are prime…”
    Get full text
    Journal Article
  4. 4

    Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer by ZIVA CERNE, Jasmina, NOVAKOVIC, Srdjan, FRKOVIC-GRAZIO, Snjezana, POHAR-PERME, Maja, STEGEL, Vida, GERSAK, Ksenija

    Published in Oncology reports (01-08-2011)
    “…Association between long-term hormone replacement therapy (HRT) use and increased risk of breast cancer is still under debate. Functionally relevant genetic…”
    Get full text
    Journal Article
  5. 5

    Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk by Ziva Cerne, Jasmina, Stegel, Vida, Gersak, Ksenija, Novakovic, Srdjan

    Published in Molecular medicine reports (01-01-2011)
    “…Published data on the association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and breast cancer risk are inconclusive. We…”
    Get full text
    Journal Article
  6. 6

    Age at menarche and menopause is not associated with two common genetic variants in the methylenetetrahydrofolate reductase (MTHFR) gene by Cerne, Jasmina-Ziva, Pohar-Perme, Maja, Cerkovnik, Petra, Gersak, Ksenija, Novakovic, Srdjan

    “…ABSTRACT Objectives The study aimed at investigating the independent and the combined effects of the two common genetic variants in the…”
    Get full text
    Journal Article
  7. 7

    Breast Tumor Characteristics in Hormone Replacement Therapy Users by Cerne, Jasmina-Ziva, Frkovic-Grazio, Snjezana, Gersak, Ksenija

    Published in Pathology oncology research (01-12-2011)
    “…The aim of this study was to further elucidate the influence of HRT use, regarding duration, regimen and route of administration, on breast tumor…”
    Get full text
    Journal Article
  8. 8

    The influence of the genetic variant within miRNA-binding site in estrogen receptor alpha gene on the risk of breast cancer in postmenopausal women on hormone replacement therapy by Cerne, Jasmina-Ziva, Gersak, Ksenija, Novakovic, Srdjan

    “…The aim of the study was to analyze the impact of the rs2747648 genetic variant in the estrogen receptor alpha (ER1) gene affecting a putative miR-453-binding…”
    Get more information
    Journal Article
  9. 9

    Breast cancer: estrogens as carcinogens by Cerne, Jasmina-Ziva, Novakovic, Srdjan, Gersak, Ksenija

    “…The major known risk factors for breast cancer are associated with a prolonged exposure to increased levels of estrogens and their reactive metabolites. The…”
    Get full text
    Journal Article
  10. 10

    Protein kinase C inhibitors sensitize GNAQ mutant uveal melanoma cells to ionizing radiation by Cerne, Jasmina Ziva, Hartig, Sean Michael, Hamilton, Mark Patrick, Chew, Sue Anne, Mitsiades, Nicholas, Poulaki, Vassiliki, McGuire, Sean Eric

    “…Uveal melanoma (UM) tumors require large doses of radiation therapy (RT) to achieve tumor ablation, which frequently results in damage to adjacent normal…”
    Get full text
    Journal Article
  11. 11

    Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome by BALDANI, DINKA PAVICIC, SKRGATIC, LANA, CERNE, JASMINA ZIVA, OGUIC, SASA KRALIK, GERSAK, BLAZ MATIJA, GERSAK, KSENIJA

    Published in Molecular medicine reports (01-05-2015)
    “…The objective of the present study was to evaluate the influence of TAAAA repeat allele length on the levels of serum sex hormone binding globulin (SHBG) and…”
    Get full text
    Journal Article
  12. 12

    Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women by Skrgatić, Lana, Baldani, Dinka Pavicić, Gersak, Ksenija, Cerne, Jasmina Ziva, Ferk, Polonca, Corić, Mario

    Published in Collegium antropologicum (01-03-2013)
    “…Obesity and insulin resistance is a common finding in patients with polycystic ovary syndrome (PCOS). Significant number of PCOS women experience insulin…”
    Get full text
    Journal Article
  13. 13

    GENETICS OF BREAST CANCER AND HORMONE REPLACEMENT THERAPY by Gersak, Ksenija, Cerne, Jasmina Ziva

    “…BACKGROUND The major known risk factors for female breast cancer are associated with prolongedexposure to increased levels of oestrogen. The predominant theory…”
    Get full text
    Journal Article
  14. 14

    GENETICS OF BREAST CANCER AND HORMONE REPLACEMENT THERAPY by Ksenija Geršak, Jasmina Živa Černe

    “…BACKGROUND The major known risk factors for female breast cancer are associated with prolongedexposure to increased levels of oestrogen. The predominant theory…”
    Get full text
    Journal Article
  15. 15

    Genetic Polymorphisms of INS, INSR and IRS-1 Genes Are Not Associated with Polycystic Ovary Syndrome in Croatian Women by Skrgatic, Lana, Pavicic Baldani, Dinka, Gersak, Ksenija, Ziva Cerne, Jasmina, Ferk, Polonca, Coric, Mario

    Published in Collegium antropologicum (03-04-2013)
    “…Obesity and insulin resistance is a common finding in patients with polycystic ovary syndrome (PCOS). Significant number of PCOS women experience insulin…”
    Get full text
    Paper
  16. 16

    THE USE OF HORMONE REPLACEMENT THERAPY IN SLOVENIAN WOMEN BEFORE THE FIRST DIAGNOSIS OF BREAST CANCER by Ksenija Geršak, Jasmina Živa Černe, Polonca Ferk, Brane Leskošek

    “…Background. The aim of our retrospective study was to collect and compare data on hormone replacement therapy prescription in Slovenian women before the first…”
    Get full text
    Journal Article